Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
US Army
Express Scripts
Harvard Business School
McKesson
Mallinckrodt
Fish and Richardson
Dow
Julphar

Generated: October 18, 2018

DrugPatentWatch Database Preview

WYAMYCIN E Drug Profile

« Back to Dashboard

Which patents cover Wyamycin E, and what generic alternatives are available?

Wyamycin E is a drug marketed by Wyeth Ayerst and is included in one NDA.

The generic ingredient in WYAMYCIN E is erythromycin ethylsuccinate. There are one hundred and three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the erythromycin ethylsuccinate profile page.

Summary for WYAMYCIN E
Drug patent expirations by year for WYAMYCIN E
Medical Subject Heading (MeSH) Categories for WYAMYCIN E
Synonyms for WYAMYCIN E
(2S,3R,4S,6R)-4-(dimethylamino)-2-(((3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-(((2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2H-pyran-2-yl)oxy)-3,5,7,9,11,13-hexamethyl-2,10-dioxooxacyclote
(3R*,4S*,5S*,6R*,7R*,9R*,11R*,12R*,13S*,14R*)-4-((2,6-Dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((2- ethyl butanedioate -3,4,6-trideoxy-3-(dimethylami
1014KSJ86F
12125-46-1
1264-62-6
1334-36-7
1386-36-3
2'-(Ethyl butanedioate)erythromycin
22372-15-2
4-18-00-07416 (Beilstein Handbook Reference)
4-O-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-di
4-O-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyloxan-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclotetradec-6-yl
41342-53-4
68206-56-4
7121-45-1
AB00051980_11
AB00051980_12
AC1L9FGS
AKOS008145410
anamycin
arpimycin
BDBM96262
BRN 0077638
BSPBio_001978
C12796
C43H75NO16
CA010379
CAS-1264-62-6
CCG-40201
CHEBI:31555
CHEMBL1200688
cid_443953
CPD000058868
CS-4434
D01361
DivK1c_000764
DSSTox_CID_2993
DSSTox_GSID_22993
DSSTox_RID_76821
DTXSID4022993
E-Mycin E
E-Mycin-E
E.E.S
E.E.S 200
E.E.S. (TN)
E.E.S. 200
E.E.S. 400
EES (Antiobiotic)
EES Granules
EINECS 215-033-8
ERITHROMYCIN ETHYL SUCCINATE
ERY-PED
EryPed
Eryped (TN)
Erythrocin ethyl succinate
Erythrocin W (TN)
erythrocinethylsuccinate
Erythromycin 2'-(ethyl butanedioate)
Erythromycin 2'-(ethyl succinate)
Erythromycin A Ethylsuccinate
Erythromycin ethyl succinate
erythromycin ethylsuccinate
Erythromycin ethylsuccinate (JP17/USP)
Erythromycin ethylsuccinate [JAN]
Erythromycin ethylsuccinate [USP:JAN]
Erythromycin mono(ethyl succinate) (ester)
Erythromycin, 2'-(ethyl butanedioate)
Erythromycin, ethyl succinate
Erythromycin, mono(ethyl succinate)
Erythromycin, mono(ethyl succinate) (ester)
erythromycin,mono(ethylsuccinate)
erythromycin,mono(ethylsuccinate)(ester)
Erythroped
Eyrthromycin Ethyl Succinate
HMS1923I21
HMS2091D03
HMS502G06
HSDB 3075
HY-B0957
IDI1_000764
KBio1_000764
KBio2_001526
KBio2_004094
KBio2_006662
KBio3_001198
KBioGR_001171
KBioSS_001526
LMPK05000001
LS-147492
MCULE-3725545409
MFCD00084692
MLS000028651
MLS001074901
MLS001076672
MolPort-003-666-180
NCGC00021382-03
NCGC00183038-01
NINDS_000764
NSC-756758
NSC756758
NSYZCCDSJNWWJL-YXOIYICCSA-N
O4-[(2S,3R,4S,6R)-4-(dimethylamino)-2-[[(3R,4S,5S,6R,7R,9R,11R,12R,13S,14R)-14-ethyl-7,12,13-trihydroxy-4-[(2R,4R,5S,6S)-5-hydroxy-4-methoxy-4,6-dimethyl-tetrahydropyran-2-yl]oxy-3,5,7,9,11,13-hexamethyl-2,10-dioxo-oxacyclote
oxo-oxacyclotetradec-6-yl]oxy]-6-methyloxan-3-yl] 1-O-ethyl butanedioate
Pediamycin
PEDIAMYCIN 400
Pharmakon1600-01500279
s4060
SAM002548941
SBI-0051367.P003
SCHEMBL18259
SMR000058868
SPBio_001045
Spectrum_001046
SPECTRUM1500279
Spectrum2_000983
Spectrum3_000419
Spectrum4_000536
Spectrum5_000668
Succinic acid monoethyl ester monoester with erythromycin
Succinic acid, monoethyl ester, monoester with erythromycin
succinicacid,monoethylester,monoesterwitherythromycin
T6531436
Tox21_113497
UNII-1014KSJ86F
Wyamycin
ZINC169356230

US Patents and Regulatory Information for WYAMYCIN E

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst WYAMYCIN E erythromycin ethylsuccinate SUSPENSION;ORAL 062123-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Wyeth Ayerst WYAMYCIN E erythromycin ethylsuccinate SUSPENSION;ORAL 062123-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
US Army
Express Scripts
Harvard Business School
McKesson
Mallinckrodt
Fish and Richardson
Dow
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.